News

October 13, 2017

Lack of SHIP1 Protein May Contribute to Inflammatory Process in Crohn’s Disease

News

A protein called SHIP1 may be involved in the progression of Crohn’s disease, according to a study conducted by researchers at SUNY Upstate Medical University and the Erasmus Medical Center, ... Read more

October 12, 2017

Compounds That Target CARD9 Protein May Be Way to Treat Bowel Diseases, Study Reports

News

Developing small-molecule compounds that can disrupt the normal functioning of the inflammation-promoting CARD9 protein could be a way to treat bowel diseases, a study reports. The protein helps the body ... Read more

October 11, 2017October 11, 2017

MRE Can Help Diagnose Active Bowel Inflammation in Children, Korean Study Finds

News

Magnetic resonance enterography (MRE) — a non-invasive, radiation-free imaging technique that lets doctors visualize the small intestine — can accurately diagnose active inflammation in children with known or suspected inflammatory ... Read more

October 10, 2017October 10, 2017

TiGenix Presents Positive Results of Potential Crohn’s Therapy, Announces Phase 3 Study

News

TiGenix will present positive results of Cx601 to treat complex perianal fistulas in Crohn’s disease patients at the upcoming World Congress of Gastroenterology ACG 2017 meeting in Orlando, Florida. The company will discuss ... Read more

October 6, 2017October 6, 2017

Fungi and Bacteria Could Be Targeted Together to Treat IBD, Study Suggests

News

Bacteria and fungi appear to work together to exacerbate certain symptoms of inflammatory bowel disease (IBD), including Crohn’s disease, a new review highlights. The study, “The mycobiome: Role in health ... Read more

October 5, 2017October 5, 2017

Genetic, Immune Biomarkers Can Help Predict Response to QBECO SSI Treatment, UC Trial Suggests

News

Detection of specific genetic alterations and immunological biomarkers can help predict the response to QBECO SSI immunotherapy in patients with inflammatory bowel disease (IBD). This finding resulted from the analysis ... Read more

October 4, 2017

Proactive Monitoring of Remicade Levels in IBD Patients May Decrease Risk of Hospitalization, Study Finds

News

Proactive monitoring of the levels of Remicade (infliximab) in patients with inflammatory bowel disease (IBD) may help promote patients’ health and decrease their hospital visits, according to scientists from the Center ... Read more

October 3, 2017

Seres’ SER-287 for UC Shows Positive Results in Phase 1b Trial

News

Seres Therapeutics announced positive topline results from the company’s Phase 1b placebo-controlled study investigating the effects of SER-287, a potential microbiome therapy, in patients with ulcerative colitis (UC) who failed ... Read more

October 2, 2017October 2, 2017

New Takeda, Karolinska Collaboration to Identify Clinical Targets in IBD

News

A new collaboration to identify and validate clinical targets in inflammatory bowel disease (IBD) was recently announced by Japan’s Takeda Pharmaceutical Company, Sweden’s Karolinska Institutet, and the Structural Genomics Consortium, a ... Read more

September 29, 2017

Probiotics Can Help Improve Gut Permeability and Reduce Systemic Inflammation, Study Finds

News

A combination of five probiotic bacteria strains in a “spore-based” formulation marketed by Microbiome Labs under the name MegaSporeBiotic reduced inflammation and endotoxin levels commonly associated with “leaky bowel” symptoms, according ... Read more